Peptide Antibiotics Industry Report 2025 | Antibiotic Resistance Crisis Fuels Demand as Market Surges Toward USD 8.4 Billion [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The Peptide Antibiotics Market was valued at USD 5.2 billion in 2024, and is projected to reach USD 8.4 billion by 2034, rising at a CAGR of 5%. The market is experiencing significant expansion due to the escalating threat of antimicrobial resistance (AMR), which has led to an urgent demand for advanced antibiotic solutions. With bacterial infections becoming increasingly resistant to conventional treatments, peptide antibiotics are emerging as a crucial alternative. These specialized antibiotics, including polymyxins and gramicidin, exhibit potent activity against multidrug-resistant (MDR) microbes, making them indispensable in combating resistant infections. As healthcare systems worldwide grapple with rising cases of antibiotic resistance, pharmaceutical companies a
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- Is ANI Pharmaceuticals Stock Price Justified After 47% 2025 Rally? [Yahoo! Finance]Yahoo! Finance
- How Investors May Respond To ANI Pharmaceuticals (ANIP) Creating a Retina-Focused FutureVision Advisory Council [Yahoo! Finance]Yahoo! Finance
- Implied Volatility Surging for ANI Pharmaceuticals Stock Options [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals (NASDAQ:ANIP) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $100.00 price target on the stock.MarketBeat
- ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina FranchiseGlobeNewswire
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 12/19/25 - Form 4
- 12/12/25 - Form 4
- 12/9/25 - Form 4
- ANIP's page on the SEC website